Eton Pharmaceuticals, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Eton Pharmaceuticals, Inc. now
Current reporting with the operating signal separated from the noise.
Analysts Expect Eton Pharmaceuticals, Inc. (NASDAQ:ETON) To Breakeven Soon
The story matters when it changes Eton Pharmaceuticals, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Eton Pharmaceuticals, Inc. (ETON) Q1 2026 Earnings Call Transcript
Investors are testing whether Eton Pharmaceuticals, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Eton Pharmaceuticals, Inc. v. Extreme v. Inc.
The story matters when it changes Eton Pharmaceuticals, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Investors are testing whether Eton Pharmaceuticals, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen
The story matters when it changes Eton Pharmaceuticals, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2023 Earnings Call Transcript
Investors are testing whether Eton Pharmaceuticals, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Eton Pharmaceuticals, Inc. (ETON) Q1 2023 Earnings Call Transcript
Investors are testing whether Eton Pharmaceuticals, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest ETON filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Eton Pharmaceuticals, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →